By: IPP Bureau
Last updated : August 12, 2024 8:44 pm
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Metropolis Healthcare Limited, one of India’s leading and reputed diagnostic chains, known for its commitment to quality and scientific excellence, announced its unaudited consolidated financial results for the quarter ended June 30, 2024.
During Q1 FY25, revenue from operations stood at Rs. 313.4 crores, a growth of 13.1% Y-o-Y basis, well within the company’s guided range of 13-15%. The company reported PAT of Rs. 38.1 crore with a growth of 31.3% Y-o-Y, margins at 12.2%, up from 10.5% for Q1FY24, up by 170 bps Y-o-Y. In Q1 FY25, growth in patient volumes and test volumes stood at 7% and 10%, respectively for the quarter.
Commenting on the result, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare Limited, said: "I am pleased to share that we have made considerable progress in the first quarter of FY 2025 with 13.1% growth, which is higher than the industry average. We have consistently achieved high growth in patient volume over the last several quarters and remain optimistic about maintaining this momentum.
"Our TruHealth (Wellness and Bundling) segment grew by 28% this quarter, which has helped us move the customers up the value chain, resulting in an increase in revenue per patient. We are confident that network expansion, increased footfalls, and a shift in test mix will continue to help us achieve our desired growth".
"Our EBITDA and PAT growth have outpaced revenue growth, driven by our focus on TruHealth wellness and bundling packages, Specialty segments, network expansion, and operational efficiencies. B2C revenue grew by 18.4%, contributing 54% of our total revenues. Our network expansion has driven a 18% revenue increase, particularly from Tier III markets, which now account for over 23% of our total revenues. We are present in over 650 towns across India and will continue to focus on growth in B2C, B2B channels, and Tier II and III towns. Looking ahead, we will leverage our brand strength, digital and AI initiatives, talented team, and trusted partnerships to drive aggressive expansion and sustainable growth, creating value for our shareholders,” added Surendran Chemmenkotil, Chief Executive Officer, Metropolis Healthcare Limited.